Unlocking New Frontiers in Kidney Diseases: Targeting Endothelial Dysfunction with Emerging Biomarkers and Therapies

Scientists showcase the potential emerging biomarkers and therapeutic targets that can effectively evaluate endothelial dysfunction across various kidney diseases, namely: acute kidney injury, chronic kidney disease, diabetic kidney disease, polycystic kidney disease, and renal cell carcinoma.